Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.639 USD | +5.62% | +14.94% | +26.76% |
05-09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
04-01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.76% | 72.85M | |
+7.43% | 111B | |
+11.27% | 106B | |
-12.70% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.70% | 16.81B | |
+37.48% | 12.54B | |
-23.94% | 8.09B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Transcript : Atara Biotherapeutics, Inc., Q3 2023 Earnings Call, Nov 01, 2023